CFDE Data Portal | Search R3HDM2P2

	Label	Description
	R3HDM2P2 associations Collection (Entity type)	Associations for R3HDM2P2_associations
	R3HDM2P2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	R3HDM2P2 Gene (Entity type)	ENSG00000216817 - R3H domain containing 2 pseudogene 2
	GSE129698 SYK inhibition 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE210093 TAF15 overexpression A-549 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	STK17A IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	PSKH2 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE193541 nifurtimox A-549 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE162696 L-13 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE162696 L-13 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

R3HDM2P2 associations

Associations for R3HDM2P2_associations

R3HDM2P2 associations.tsv

A file from IDG as part of the Harmonizome project

R3HDM2P2

ENSG00000216817 - R3H domain containing 2 pseudogene 2

GSE129698 SYK inhibition 7 v 5 human dn

A Gene Set from LINCS

GSE210093 TAF15 overexpression A-549 0 v 2 human dn

A Gene Set from LINCS

STK17A IDG kinase ARCHS4 coexpression

A Gene Set from IDG

PSKH2 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

GSE193541 nifurtimox A-549 1 v 3 human up

A Gene Set from LINCS

GSE162696 L-13 3 v 1 human up

A Gene Set from LINCS

GSE162696 L-13 2 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.